文 | 银发财经 对行动不便者而言，独立出行曾是难题，而智能轮椅这一设备，正是科研者与创业者秉持"助力行动自 由"的初心，用四十年从实验室雏形打磨而成的智能辅助工具。 本文将跳过晦涩术语与生硬数据，聚焦智能轮椅四十年的发展历程，探寻其从实验室走向现实的坚守与 突破"。 1. 1986-2005年，开荒年代——只为证明"这件事，能成" 上世纪80年代，全球科技尚处懵懂期，计算机笨重、传感器精度不足，但一群科研者率先提出设想：让 轮椅实现自主移动、无需人力操控，这便是智能轮椅四十年征程的起点。 这一阶段毫无商业化诉求，所有参与者的核心目标只有一个：验证"机器人技术可应用于轮椅"的可行 性。 1986年，亚利桑那州立大学科研团队做出第一台自主轮椅原型机——将普通轮椅连接笨重计算机和简易 传感器，虽能勉强自主移动，却无法有效避障，极易"卡壳"。但这台粗糙的原型机，为行业奠定了信 心：这件事，能成。 此后十几年，"开荒者"不断增多：1992年日本NEC推出自动导向轮椅，可在固定路线自主导航，拓宽了 应用想象；密歇根大学研发的NavChair辅助导航系统，以"辅助省力"为核心，帮助上肢障碍用户实现独 立操控，成为"共享控 ...

近日，「发推狂魔」马斯克转发了一个帖子，Neuralink 植入脑芯片的患者，现在已经能靠脑子里的意念直接玩游戏了，完全不需要手柄、鼠标、键盘啥 的控制器。 对于网友「我们正生活在未来，这太神奇了」的感叹，马斯克只简单地回复了一个「Yup」。 截至目前，Neuralink 在全球范围内已有 21 人参与其 Telepathy（心灵感应）植入设备的临床试验，这一数字相比去年 9 月的 12 人有了显著增长。 这些植入设备专门为瘫痪患者设计，帮助他们仅通过思维就能控制电脑、游戏和各类数字工具。 他们可以浏览互联网、流畅地移动屏幕光标，甚至玩电子游戏，所有这些都不需要动一根手指。 马斯克的 Neuralink 做的事，即使放到现在，也感觉像是科幻电影里的情节。 有网友评论称，大约十五年前，他还是本科生时，第一次对脑机接口（BCI）产生兴趣并参与相关研究，当时他觉得这就像一种梦幻般的科技，实际落地 似乎遥遥无期，进展也非常缓慢，因为当时的公司并不认为它具有商业可行性。如今看到这个梦想一点点变成现实，真是令人振奋。 脑机接口：瘫痪患者用「意念」玩游戏、打字 早期试验参与者的日常生活已经因这项技术发生了实质性改变。 一开 ...

编辑｜杨文 近日，「发推狂魔」马斯克转发了一个帖子，Neuralink 植入脑芯片的患者，现在已经能靠脑子里的意念直接玩游戏了，完全不需要手柄、鼠标、键盘啥的控制 器。 有网友评论称，大约十五年前，他还是本科生时，第一次对脑机接口（BCI）产生兴趣并参与相关研究，当时他觉得这就像一种梦幻般的科技，实际落地似乎遥 遥无期，进展也非常缓慢，因为当时的公司并不认为它具有商业可行性。如今看到这个梦想一点点变成现实，真是令人振奋。 这些植入设备专门为瘫痪患者设计，帮助他们仅通过思维就能控制电脑、游戏和各类数字工具。 对于网友「我们正生活在未来，这太神奇了」的感叹，马斯克只简单地回复了一个「Yup」。 截至目前，Neuralink 在全球范围内已有 21 人参与其 Telepathy（心灵感应）植入设备的临床试验，这一数字相比去年 9 月的 12 人有了显著增长。 马斯克的 Neuralink 做的事，即使放到现在，也感觉像是科幻电影里的情节。 脑机接口：瘫痪患者用「意念」玩游戏、打字 早期试验参与者的日常生活已经因这项技术发生了实质性改变。 他们可以浏览互联网、流畅地移动屏幕光标，甚至玩电子游戏，所有这些都不需要动一根 ...

瑞银近期举办了一场脑机接口商业化的专家电话会议，核心结论非常明确：虽然目前中国在脑机接口 （BCI）核心技术上落后美国约两年，但这一差距预计在两年后将显著缩小。 1月13日，据追风交易台消息，瑞银最新研报称，在近日举办的脑机接口行业专家电话会上，专家表 示，尽管目前中国企业在该领域落后美国约两年，但随着产品成熟度提升和应用场景扩展，中国BCI市 场预计将迎来指数级增长。 专家透露中国BCI产品正处于不同的研发和商业化阶段。非侵入式产品已有在售产品，预计未来6至12 个月将有更多产品上市。半侵入式产品预计1至2年内首次在中国上市，而侵入式产品可能在2至3年内推 出。 专家预计，到2030年，中国BCI产品的整体市场规模可能达到数百亿元人民币。其中，非侵入式产品预 计将占据至少70%的市场份额，显著高于半侵入式和侵入式产品。 技术差距：目前落后两年，硬件与算法是核心短板 研报称，专家在电话会上指出，目前中国本土企业的BCI技术与美国同行（如Neuralink）相比，存在约 两年的差距。但这一差距并非不可逾越，预计在两年后将开始"有意义地"缩小。 在电极技术方面，美国企业的设备和加工技术更为先进。例如，中国的通道数 ...

Core Viewpoint - Neuralink technology has the potential to help paralyzed individuals regain full body function, theoretically allowing them to walk again or restore movement, which is a significant advancement in medical technology [7][8][10]. Group 1: Technological Advancements - Neuralink acts as a communication bridge, connecting brain signals to other body parts, bypassing damaged areas in the neck or spine [7]. - The technology has shown promising early results in paralysis treatment and brain-computer interfaces, indicating that restoring lost motor function is becoming a feasible engineering and clinical challenge [12][13]. - An upgraded surgical robot was launched in 2025, enhancing the efficiency, safety, and cost-effectiveness of brain implant surgeries, aiming to reduce the procedure time to just a few minutes [20][21]. Group 2: Clinical Trials and Regulatory Progress - Neuralink has received "breakthrough device designation" from the FDA for its speech recovery technology, which is expected to expedite further development and review processes [16]. - International clinical trials have commenced in the Middle East, Canada, and the UK, with the first surgeries conducted outside the U.S. [17]. - As of September 2025, 12 severely paralyzed patients have undergone implantation, although long-term safety and efficacy data are still being accumulated [45]. Group 3: Financial Aspects - Neuralink completed a Series E funding round, raising $650 million, with a valuation of approximately $9 billion, reflecting investor confidence in brain-computer interface technology [22][23]. Group 4: Future Outlook - Neuralink plans to begin mass production of brain-computer interface devices in 2026, utilizing a simplified and nearly fully automated surgical process [27][32]. - The technology is expected to transition from experimental neuroscience to scalable clinical reality, potentially marking 2026 as a pivotal year for brain-computer interfaces [33][34]. Group 5: Challenges Ahead - The company faces multiple challenges, including regulatory approvals, clinical trial data accumulation, and potential complications such as surgical infections or electrode displacement [45][46]. - Engineering challenges remain, such as ensuring compatibility with anatomical variations and addressing long-term effects on brain tissue [48]. - Ethical concerns regarding privacy, autonomy, and the implications of human-machine integration are significant hurdles that need to be addressed [52].

Core Insights - The article highlights the emergence of BrainCo, a consumer-grade brain-computer interface (BCI) mattress developed by Xilinmen, marking a significant technological advancement in the sleep industry [1][4][10] - Xilinmen's recent rebranding to Xilinmen Health Sleep Technology Co., Ltd. emphasizes its long-standing commitment to sleep technology rather than merely being a furniture manufacturer [1][11] Group 1: Technological Foundation - Xilinmen has a rich technological heritage, having pioneered the first ultrasonic pocket spring mattress in China in 1996, which marked a breakthrough in the domestic mattress industry [2][12] - Over the years, Xilinmen has developed various innovative technologies, including air spring technology in 2018 and the Smart1 intelligent mattress in 2020, culminating in the launch of the BrainCo mattress in 2025 [2][12][14] - The company has invested over 1.2 billion yuan in R&D over the past decade, resulting in 2,376 effective patents and collaborations with top universities and research institutions [3][13] Group 2: Market Position and Product Innovation - The flagship product, the BrainCo mattress, integrates brainwave monitoring with intelligent adjustment technology, achieving a global breakthrough in the commercialization of BCI technology [4][14] - The mattress series has received the highest L4 certification for smart mattresses, showcasing Xilinmen's leadership in the global sleep technology market [4][14] - Xilinmen is transforming traditional mattresses into health management hubs by integrating sleep data with smart home ecosystems, enhancing their functionality beyond mere sleep support [5][15] Group 3: Market Trends and Future Outlook - The global sleep market is projected to reach $67.76 billion by 2024, with a significant increase in demand for wearable devices and smart bedding products [6][17] - In China, the sleep economy has grown from 261.63 billion yuan in 2016 to 495.58 billion yuan in 2023, indicating a shift towards high-value AI-assisted sleep products [6][17] - Xilinmen has established a robust competitive barrier through comprehensive technological capabilities, extensive production capacity, and a strong brand presence, serving 60 million households and entering 3,000 star-rated hotels [6][17] Group 4: Long-term Vision and Health Integration - Xilinmen's strategic focus on sleep technology aligns with the "Healthy China 2030" initiative, aiming to integrate sleep data into broader health management systems [9][18] - The company's vision for smart sleep terminals includes continuous monitoring of neurological states and early warning systems for emotional or cognitive disorders, contributing to overall health and longevity [7][18] - The evolution of sleep technology is expected to redefine the boundaries of traditional home furnishings, positioning sleep products as essential components of the health industry [9][18][19]

Core Insights - The article highlights the emergence of BrainCo, the world's first consumer-grade brain-computer interface (BCI) mattress, developed by Xilinmen, a company transitioning from traditional furniture to a health-focused sleep technology firm [1][10]. Group 1: Company Background and Technological Evolution - Xilinmen has a rich technological heritage, having pioneered the first ultrasonic pocket spring mattress in China in 1996, marking a significant breakthrough in the mattress industry [2]. - Over the years, Xilinmen has developed various innovative technologies, including the unique air spring technology in 2018, and has focused on smart mattress solutions, culminating in the launch of the BrainCo mattress in 2025 [2][5]. - The company has invested over 1.2 billion yuan in R&D over the past decade, resulting in 2,376 effective patents, and has established collaborative research centers with top universities to advance sleep technology [3][4]. Group 2: Product and Market Positioning - The BrainCo mattress integrates brainwave monitoring with intelligent adjustment technology, providing real-time data capture and sleep intervention, positioning Xilinmen at the forefront of sleep technology [5][6]. - The flagship product series, including the BrainCo mattress, has achieved the highest L4 certification for smart mattresses, indicating a significant advancement in the industry [5]. - The global sleep market is projected to reach $67.76 billion in 2024, with a notable increase in demand for smart sleep products, reflecting a shift towards high-value technology-driven solutions in the sleep industry [7]. Group 3: Strategic Vision and Future Outlook - Xilinmen aims to transform traditional mattresses into core nodes of family health management, integrating sleep data with smart home ecosystems [6][9]. - The company's strategic shift aligns with China's "Healthy China 2030" initiative, emphasizing the importance of sleep technology in health management and disease prevention [9]. - The evolution of Xilinmen from a traditional mattress manufacturer to a sleep technology company exemplifies a broader industry trend towards integrating technology into health and wellness solutions [10].

Core Viewpoint - The company, Yahua Electronics, is focusing on the integration of its smart communication systems for hospital wards with brain-computer interface (BCI) technology, aiming to innovate in medical and care scenarios through technological advancements [1] Group 1: Company Developments - Yahua Electronics has announced its smart communication interactive system for hospital wards can achieve preliminary integration with brain-computer interface (BCI) technology [1] - The company is dedicated to the research and development of smart communication systems in hospitals, emphasizing the application of new technologies such as BCI, IoT, and AI in medical and care environments [1]

Core Viewpoint - Neuralink is making significant advancements in brain-computer interface (BCI) technology, aiming to enhance the quality of life for patients with paralysis and other neurological conditions through innovative surgical techniques and devices [1][4]. Group 1: Technological Advancements - The speed of the new generation surgical robot for implanting single electrode wires has improved from 17 seconds to 1.5 seconds, making it adaptable for 99% of the global population [2]. - Over a dozen subjects are currently using the device for 8 hours daily, with more than 10,000 patients waiting for treatment [2]. - The new surgical robot has increased the speed of inserting single electrode wires by several times compared to existing robots [2]. - Neuralink is developing a new type of implant needle capable of penetrating over 50mm into the brain's surface to access a richer array of neurons [2][12]. - The manufacturing cost of the needle holder has been reduced by 95% [2]. Group 2: BCI Technology and Applications - BCI technology translates neural signals into output commands, enabling control of external devices, with initial goals focused on improving the lives of millions of paralyzed patients [4]. - The first product, "Telepathy," allows individuals with spinal cord injuries or ALS to control computers and mobile devices through thought [15]. - A subject was able to play the game "Civilization VI" for 9 hours after receiving the BCI implant, showcasing the potential for everyday applications [15]. Group 3: Future Prospects - Neuralink has made continuous technological progress since its establishment in 2016, with the first human brain chip implantation scheduled for 2024 [12]. - The company aims to make surgeries as routine as LASIK eye surgery, potentially completing procedures within an hour and even while patients are awake [6]. - The long-term vision includes achieving a high-density device with thousands of channels to record more neurons and gather more information [12].

Core Insights - The 2025 International Frontier Technology Forum on Health Engineering, hosted by Tsinghua SIGS, focuses on the integration of artificial intelligence and biomedical technologies to revolutionize healthcare [3][5] - The forum gathered nearly 100 top scholars and industry representatives to discuss advancements in health technology, including automated antibody discovery and engineered bacteria for cancer treatment [3][4] Group 1: Forum Overview - The forum featured a main session with 20 invited reports and 4 parallel sessions with over 50 thematic presentations, showcasing the latest breakthroughs in biomedical and health engineering [3] - Attendees included over 300 participants from universities, research institutions, and companies, highlighting the collaborative nature of the event [3] Group 2: Key Presentations - Professor Zhang Linqi from Tsinghua University introduced the fully automated antibody discovery platform, MabSeek, which accelerates antibody lead screening and functional identification [3][4] - Professor Ernst Wagner discussed the development of novel RNA delivery carriers through "chemical evolution" strategies applicable to multiple organs [4] - Professor Zeng Fanggang proposed a gradual establishment of clinical foundations and commercial development for brain-computer interfaces, focusing on safety, efficacy, and regulatory pathways [4] Group 3: Research Contributions - The forum included a poster presentation segment that attracted hundreds of submissions from graduate students across various universities, fostering an environment of active exchange and collaboration [4][5] - Awards were given for outstanding research contributions, with 3 first prizes, 7 second prizes, and 11 third prizes recognized by expert evaluation [5]